168 related articles for article (PubMed ID: 20527227)
1. Future directions in the field of endometrial cancer research: the need to investigate the tumor microenvironment.
Felix AS; Weissfeld J; Edwards R; Linkov F
Eur J Gynaecol Oncol; 2010; 31(2):139-44. PubMed ID: 20527227
[TBL] [Abstract][Full Text] [Related]
2. Induction of hepatocyte growth factor in stromal cells by tumor-derived basic fibroblast growth factor enhances growth and invasion of endometrial cancer.
Yoshida S; Harada T; Iwabe T; Taniguchi F; Fujii A; Sakamoto Y; Yamauchi N; Shiota G; Terakawa N
J Clin Endocrinol Metab; 2002 May; 87(5):2376-83. PubMed ID: 11994390
[TBL] [Abstract][Full Text] [Related]
3. Impact of oestrogen and progesterone receptor expression in the cancer cells and myometrium on survival of patients with endometrial cancer.
Tomica D; Ramić S; Danolić D; Šušnjar L; Perić-Balja M; Puljiz M
J Obstet Gynaecol; 2018 Jan; 38(1):96-102. PubMed ID: 28764605
[TBL] [Abstract][Full Text] [Related]
4. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.
Giannice R; Erreni M; Allavena P; Buscaglia M; Tozzi R
Cytokine; 2013 Nov; 64(2):509-15. PubMed ID: 23985752
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis.
Teng F; Tian WY; Wang YM; Zhang YF; Guo F; Zhao J; Gao C; Xue FX
J Hematol Oncol; 2016 Feb; 9():8. PubMed ID: 26851944
[TBL] [Abstract][Full Text] [Related]
6. EXPRESSION OF HEPATOCYTE GROWTH FACTOR AND C-MET RECEPTOR IN STROMAL FIBROBLASTS AND TUMOR CELLS OF ENDOMETRIAL CARCINOMA.
Buchynska LG; Brieieva OV; Nespriadko SV
Exp Oncol; 2023 Jun; 45(1):79-87. PubMed ID: 37417279
[TBL] [Abstract][Full Text] [Related]
7. Chemokines and Cancer Progression: A Qualitative Review on the Role of Stromal Cell-derived Factor 1-alpha and CXCR4 in Endometrial Cancer.
Felix AS; Edwards R; Bowser R; Linkov F
Cancer Microenviron; 2010 Feb; 3(1):49-56. PubMed ID: 21209774
[TBL] [Abstract][Full Text] [Related]
8. Stromal Clues in Endometrial Carcinoma: Loss of Expression of β-Catenin, Epithelial-Mesenchymal Transition Regulators, and Estrogen-Progesterone Receptor.
Senol S; Sayar I; Ceyran AB; Ibiloglu I; Akalin I; Firat U; Kosemetin D; Engin Zerk P; Aydin A
Int J Gynecol Pathol; 2016 May; 35(3):238-48. PubMed ID: 26367784
[TBL] [Abstract][Full Text] [Related]
9. STAR and AKR1B10 are down-regulated in high-grade endometrial cancer.
Sinreih M; Štupar S; Čemažar L; Verdenik I; Frković Grazio S; Smrkolj Š; Rižner TL
J Steroid Biochem Mol Biol; 2017 Jul; 171():43-53. PubMed ID: 28232277
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of stromal versican expression in human endometrial cancer.
Kodama J; Hasengaowa ; Kusumoto T; Seki N; Matsuo T; Ojima Y; Nakamura K; Hongo A; Hiramatsu Y
Ann Oncol; 2007 Feb; 18(2):269-74. PubMed ID: 17065588
[TBL] [Abstract][Full Text] [Related]
11. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
[TBL] [Abstract][Full Text] [Related]
12. Could E-Cadherin and CD10 Expression be Used to Differentiate Between Atypical Endometrial Hyperplasia and Endometrial Carcinoma?
Youssef MY; Mohamed MA
Int J Gynecol Pathol; 2019 Mar; 38(2):128-137. PubMed ID: 30726192
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Wnt7a is associated with tumor progression and unfavorable prognosis in endometrial cancer.
Liu Y; Meng F; Xu Y; Yang S; Xiao M; Chen X; Lou G
Int J Gynecol Cancer; 2013 Feb; 23(2):304-11. PubMed ID: 23321718
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic characterization of endometrial stromal sarcoma of the uterus.
Yamada K; Kano J; Tsunoda H; Yoshikawa H; Okubo C; Ishiyama T; Noguchi M
Cancer Sci; 2006 Feb; 97(2):106-12. PubMed ID: 16441420
[TBL] [Abstract][Full Text] [Related]
15. Type 2 Endometrial Cancer is Associated With a High Density of Tumor-Associated Macrophages in the Stromal Compartment.
Kelly MG; Francisco AM; Cimic A; Wofford A; Fitzgerald NC; Yu J; Taylor RN
Reprod Sci; 2015 Aug; 22(8):948-53. PubMed ID: 25701837
[TBL] [Abstract][Full Text] [Related]
16. The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis.
Nascimento AF; Hirsch MS; Cviko A; Quade BJ; Nucci MR
Mod Pathol; 2003 Jan; 16(1):22-7. PubMed ID: 12527709
[TBL] [Abstract][Full Text] [Related]
17. Proteomic Analysis of Stromal and Epithelial Cell Communications in Human Endometrial Cancer Using a Unique 3D Co-Culture Model.
Al-Juboori AAA; Ghosh A; Jamaluddin MFB; Kumar M; Sahoo SS; Syed SM; Nahar P; Tanwar PS
Proteomics; 2019 Nov; 19(21-22):e1800448. PubMed ID: 30865368
[TBL] [Abstract][Full Text] [Related]
18. Kisspeptin-10 inhibits stromal-derived factor 1-induced invasion of human endometrial cancer cells.
Schmidt E; Haase M; Ziegler E; Emons G; Gründker C
Int J Gynecol Cancer; 2014 Feb; 24(2):210-7. PubMed ID: 24407584
[TBL] [Abstract][Full Text] [Related]
19. Endometrial stromal nodules and endometrial stromal tumors with limited infiltration: a clinicopathologic study of 50 cases.
Dionigi A; Oliva E; Clement PB; Young RH
Am J Surg Pathol; 2002 May; 26(5):567-81. PubMed ID: 11979087
[TBL] [Abstract][Full Text] [Related]
20. [Expressions of stromal cell-derived factor-1 and CXCR4 in endometrial carcinoma tissues and cell lines].
Li XP; Zhao D; Gao M; Wang JL; Wei LH
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):458-62. PubMed ID: 17068613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
